Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.

Status: Enrolling by invitation
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The induction dose of rocuronium is typically decided based on the patient's body weight, but the effect duration of rocuronium is variable. Some studies suggest that body composition analysis data, such as skeletal muscle mass or total body water, may correlate better with the duration time of rocuronium. Therefore, we plan to analyse body composition in patients undergoing total intravenous general anesthesia, give the patients a fixed dose (50mg) of rocuronium, and check the correlation between duration time of rocuronium and body composition analysis data.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: No
View:

• Adult patients with ASA class I-II undergoing total intravenous general anesthesia

Locations
Other Locations
Republic of Korea
Samsung Medical Center, Sungkyunkwan University, School of Medicine
Seoul
Time Frame
Start Date: September 5, 2022
Estimated Completion Date: March 2023
Participants
Target number of participants: 88
Treatments
rocuronium
The patient will be given 50mg of rocuronium intravenously for induction.
Sponsors
Leads: Samsung Medical Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials